A Registry Study on Biomarkers of Takayasu's Arteritis (ARSBTA)
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- Это наблюдательное исследование: исследуемое лечение участникам по протоколу не назначают.
- Кому может быть актуально
- Состояния в реестре: Takayasu's Arteritis. Базовые параметры: 18 лет — 70 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Китай
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
A Registry Study on Biomarkers of Takayasu's Arteritis
Обзор
Takayasu arteritis is a chronic vasculitis mainly involving the aorta and its main branches such as the brachiocephalic, carotid, subclavian, vertebral, and renal arteries, as well as the coronary and pulmonary arteries. Inflammation causes segments of the vessels to become narrowed, blocked, or even stretched, possibly resulting in aneurysms. The disease is very rare but most commonly occurs in young Asian women. However, there is a considerable lack of understanding of the disease mechanism of Takayasu arteritis. Initially, the disease remains clinically silent (or remains undetected) until the patients present with vascular occlusion. Additionally, many individuals with Takayasu arteritis, however, have no apparent symptoms despite disease activity. Therefore, biomarkers for diagnosis and monitor disease activity in individuals with Takayasu arteritis are needed. In this study, the investigators therefore to use different methods to identify new biomarkers for diagnosing or monitoring the disease activity in individuals with Takayasu arteritis. These biomarkers may provide valuable insights into the underlying biochemical processes and aid the understanding of the pathophysiology of this disease.
Первичные конечные точки
- Diagnosis of each participant [Срок оценки: These data is collected from the cases' medical record in an average of 3 month after the sample recruiting.]
- Disease activity of each participant [Срок оценки: These data is collected from the cases' medical record or during follow-up visit in an average of 6 month after the sample recruiting.]
Критерии участия
Retrospective
Критерии включения
Subjects who met the American College of Rheumatology 1990 classification criteria for Takayasu arteritis:
- Age of onset ≤40 years,
- Claudication of upper or lower extremities,
- Decreased pulsation of 1 or both brachial arteries,
- Difference of ≥ 10 mmHg in systolic blood pressure between arms,
- Bruit over subclavian arteries or aorta,
- \*Arteriographic evidence showing a branch of the aorta stenosis or occlusion.
Meeting more than 3 of 6 criteria suggests the diagnosis of Takayasu arteritis.
\*Angiography in this study was replaced by vascular magnetic resonance angiography(MRA)or computed tomography angiography(CTA).
Критерии исключения
- Arteriographic lesions that could be entirely due to atherosclerosis,
- Suffer from other autoimmune diseases (eg, ANCA-associated vasculitis, systemic lupus erythematosus, etc.) besides Takayasu arteritis,
- Cogan's syndrome,
- Behcet's disease,
- Subjects with any serious acute or chronic infection,
- Giant cell arteritis (large vessel vasculitis and at least 50 years old) or other infectious forms of large vessel vasculitis.
Prospective
Критерии включения
Subjects with initial suspicion of having Takayasu arteritis or patients with Takayasu arteritis need assessment of disease activity were prospectively enrolled.
Критерии исключения
- Patients without image studies.
- Patients with confirmed other autoimmune diseases (eg, ANCA-associated vasculitis, systemic lupus erythematosus, etc.)
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Да
Дизайн исследования
- Модель наблюдения
- Когортное
Центры проведения
Китай · 1 центр
- Beijing Anzhen Hospital — Пекин
Идентификаторы
NCT: NCT03372980 · ARSBTA